Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Cardiac CaV1.2 channels require β subunits for β-adrenergic–mediated modulation but not trafficking
Lin Yang, … , Henry M. Colecraft, Steven O. Marx
Lin Yang, … , Henry M. Colecraft, Steven O. Marx
Published November 13, 2018
Citation Information: J Clin Invest. 2019;129(2):647-658. https://doi.org/10.1172/JCI123878.
View: Text | PDF
Research Article Cardiology Muscle biology

Cardiac CaV1.2 channels require β subunits for β-adrenergic–mediated modulation but not trafficking

  • Text
  • PDF
Abstract

Ca2+ channel β-subunit interactions with pore-forming α-subunits are long-thought to be obligatory for channel trafficking to the cell surface and for tuning of basal biophysical properties in many tissues. Unexpectedly, we demonstrate that transgenic expression of mutant α1C subunits lacking capacity to bind CaVβ can traffic to the sarcolemma in adult cardiomyocytes in vivo and sustain normal excitation-contraction coupling. However, these β-less Ca2+ channels cannot be stimulated by β-adrenergic pathway agonists, and thus adrenergic augmentation of contractility is markedly impaired in isolated cardiomyocytes and in hearts. Similarly, viral-mediated expression of a β-subunit–sequestering peptide sharply curtailed β-adrenergic stimulation of WT Ca2+ channels, identifying an approach to specifically modulate β-adrenergic regulation of cardiac contractility. Our data demonstrate that β subunits are required for β-adrenergic regulation of CaV1.2 channels and positive inotropy in the heart, but are dispensable for CaV1.2 trafficking to the adult cardiomyocyte cell surface, and for basal function and excitation-contraction coupling.

Authors

Lin Yang, Alexander Katchman, Jared Kushner, Alexander Kushnir, Sergey I. Zakharov, Bi-xing Chen, Zunaira Shuja, Prakash Subramanyam, Guoxia Liu, Arianne Papa, Daniel Roybal, Geoffrey S. Pitt, Henry M. Colecraft, Steven O. Marx

×

Figure 2

AID-mutant CaV1.2 channels lack β-adrenergic regulation.

Options: View larger image (or click on image) Download as PowerPoint
AID-mutant CaV1.2 channels lack β-adrenergic regulation.
(A) Normalized ...
(A) Normalized CaV1.2 current-voltage relationships for transgenic pWT and AID-mutant α1C cardiomyocytes in the presence of nisoldipine (n = 19 cardiomyocytes from 3 pWT α1C transgenic mice; n = 18 cardiomocytes from 6 AID-mutant α1C transgenic mice). (B and C) Bar graphs of Boltzmann function parameters Vmid and slope (Vc). **P < 0.01, ANOVA and Sidak’s multiple comparison test; n = 19 cardiomyocytes from 3 pWT α1C transgenic mice; n = 18 cardiomocytes from 6 AID-mutant α1C transgenic mice. (D) Summary of time constants of inactivation at the indicated potentials obtained from a single exponential fit (n = 24 pWT α1C cardiomyocytes from 4 mice and n = 24 AID-mutant α1C cardiomyocytes from 4 mice). P > 0.05 pWT versus AID-mutant for all voltages using Sidak’s multiple comparison test. (E and F) Exemplar nisoldipine-resistant current-voltage relationships of transgenic pWT α1C (E) and AID-mutant α1C (F) acquired in the absence (black trace) and presence of 200 nM isoproterenol (red trace). (G) Diary plot of normalized nisoldipine-resistant ICa amplitude at 0 mV (normalized to 1 at 50 seconds prior to isoproterenol) of pWT and AID-mutant α1C cardiomyocytes. Cells exposed to 300 nM nisoldipine followed by 200 nM isoproterenol in the continued presence of nisoldipine. pWT, n = 30 cardiomyocytes from 5 mice; AID-mutant, n = 45 cardiomyocytes from 7 mice. P < 0.0001 by 1-way ANOVA/multiple comparison at all time points 30 seconds after isoproterenol. (H) Diary plot of normalized nisoldipine-resistant ICa amplitude at +10 mV (normalized to 1 at 50 seconds, prior to forskolin) of pWT and AID-mutant α1C cardiomyocytes. Cells exposed to 300 nM nisoldipine followed by 10 μM forskolin in the continued presence of nisoldipine. pWT: n = 15 cardiomyocytes from 2 mice; AID-mutant: n = 20 cardiomyocytes from 6 mice. P < 0.0001 by 1-way ANOVA/multiple comparison at all time points 30 seconds after forskolin. (I) Bar graph of isoproterenol- or forskolin-induced fold increase in nisoldipine-resistant ICa. Mean ± SEM. ***P < 0.001; ****P < 0.0001 by t test. (J) Graph of isoproterenol- and forskolin-induced increase in nisoldipine-resistant current stratified by total basal current density before nisoldipine for pWT α1C and AID-mutant α1C transgenic mice. Lines fitted by linear regression for pWT cells for isoproterenol (black) and forskolin (red). For isoproterenol, pWT α1C, n = 29 cardiomyocytes; AID-mutant α1C, n = 45 cardiomyocytes. For forskolin, pWT α1C, n = 17 cardiomyocytes; AID-mutant α1C, n = 9 cardiomyocytes.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts